High cleanliness exceeding the GMP standard
The production environment maintains high cleanliness using high performance filters. Automatic lines prevent
the mixture of microorganisms and foreign sub-stances. Safe and effective vaccines with high purity are produced using automated apparatuses for bacterial large scale culture and purification. Products that have passed in-house assays and national assays are delivered to various countries.
Acquisition of strict FDA approval
The U.S.FDA approved the production of acelluar pertussis vaccine as a bulk material and lyophilized Japanese encephalitis
vaccine in 1992. We are proud that our facilities and vaccines met the strict FDA requirements.
